Dr. Zuniga is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
72 E Main St Ste 1
Babylon, NY 11702Phone+1 631-751-3000Fax+1 978-788-7966
Education & Training
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 2009 - 2012
- Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 2004 - 2007
- University of San Martin de Porres Faculty of MedicineClass of 2003
Certifications & Licensure
- NY State Medical License 2012 - 2026
- MA State Medical License 2015 - 2020
- TX State Medical License 2011 - 2013
- MI State Medical License 2004 - 2011
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer Start of enrollment: 2017 Jan 18
Publications & Presentations
PubMed
- 215 citationsEfficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan.Richard Zuniga, Roy Torcuator, Rajan Jain, Joseph Anderson, Thomas J. Doyle
Journal of Neuro-Oncology. 2009-02-01 - 50 citationsRhenium-186 liposomes as convection-enhanced nanoparticle brachytherapy for treatment of glioblastomaWilliam T. Phillips, Beth A. Goins, Ande Bao, Daniel Vargas, Juan E. Guttierez
Neuro-Oncology. 2012-04-01 - 23 citationsHypoxia-activated evofosfamide for treatment of recurrent bevacizumab-refractory glioblastoma: a phase I surgical study.Andrew Brenner, Richard Zuniga, Jessica D Sun, John Floyd, Charles P. Hart
Neuro-Oncology. 2018-08-02
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: